BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BRIM Biotechnology, Inc. raises $20 million in Series E funding round

Since the company’s inception in 2013, BRIM has successfully developed several platform technologies, including the regenerative peptide technology (...

December 05, 2022 | News

Inventia enters into a distribution agreement for RASTRUM™ with SCRUM Inc in Japan

RASTRUM™, is a game-changing 3D cell culture platform that’s accelerating the quest to cure cancer and debilitating diseases. With applications...

December 05, 2022 | News

Scipio bioscience announces single-cell Grant Program for four researchers valued up to US$30,000

With the debut of its novel single-cell solution and its first Grant Program, Scipio bioscience is creating an era where scRNA-seq is versatile, flexible, ...

December 02, 2022 | News

Rocket Pharmaceuticals Completes Acquisition of Renovacor

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic th...

December 02, 2022 | News

MGI Cements Its Presence and Contribution in Singapore's Genomics Landscape at ESMO Asia Congress 2022

At ESMO, MGI sets to showcase its MGISP-100 Automated Sample Preparation System and DNBSEQ-G99* Genetic Sequencer at Booth C209. Suitable for small and med...

December 02, 2022 | News

New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio

ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to the foundational CRISPR/Cas9 intellectual ...

December 01, 2022 | News

SOTIO Exercises Option for Novel Antibody-Drug Conjugate Program under Agreement with LegoChem Biosciences

SOT106 is an antibody-drug conjugate (ADC) targeting an attractive surface antigen expressed on multiple solid tumors Preclinical efficacy and tolerabil...

November 30, 2022 | News

Full-Life Technologies to Acquire Focus-X Therapeutics

Acquisition accelerates Full-Life's transformation into clinical stage radiopharmaceutical company, leveraging its European-focused Radiotechnology and Dev...

November 29, 2022 | News

BioPharma Dynamics provides cell media solutions for the Cell and Gene Therapy industry

BioPharma Dynamics, a leading life sciences solution provider, proudly expand their extensive portfolio for the Cell & Gene Therapy market to offer a r...

November 29, 2022 | News

Chemotherapy may be completed within 8 days with two doses of Polytaxel, an innovative anticancer drug from South Korea's biotech firm

Polytaxel, a novel pain-free anticancer drug, may not require break periods A new standard of care, more convenient than docetaxel, is suggest...

November 28, 2022 | News

BRIM Biotechnology, Inc. raises $20 million in Series E funding round

Inventia enters into a distribution agreement for RASTRUM™ with SCRUM Inc in Japan

Scipio bioscience announces single-cell Grant Program for four researchers valued up to US$30,000

Rocket Pharmaceuticals Completes Acquisition of Renovacor

MGI Cements Its Presence and Contribution in Singapore's Genomics Landscape at ESMO Asia Congress 2022

New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio

SOTIO Exercises Option for Novel Antibody-Drug Conjugate Program under Agreement with LegoChem Biosciences

Full-Life Technologies to Acquire Focus-X Therapeutics

BioPharma Dynamics provides cell media solutions for the Cell and Gene Therapy industry

Chemotherapy may be completed within 8 days with two doses of Polytaxel, an innovative anticancer drug from South Korea's biotech firm

Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility

Merck to Acquire Imago BioSciences, Inc.

Indonesia to Advance Genomic Sequencing and Bioinformatics

New CRISPR/Cas9 Agreement for ERS Genomics and ATLATL

Stay Connected